Skip to main content
SpringerLink
Log in
Book cover

Multiple Myeloma pp 3–23Cite as

History of Multiple Myeloma

  • Chapter
  • First Online:

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 183))

Abstract

Multiple Myeloma has been recognized since Ancient Times. The first well-documented case was reported in 1844 by Samuel Solly. The most commonly recognized case is that of Thomas Alexander McBean, a highly respectable tradesman from London in 1850. Mr. McBean excreted a large amount of protein that was described by Henry Bence Jones in the middle of the 19th century. Jones was a well-known physician and made many contributions to medicine. One of the best known cases of multiple myeloma was that of Dr. Loos that was reported by Otto Kahler. The recognition of plasma cells and subsequently their product, a monoclonal protein has been described in detail. The authors have reviewed the treatment of multiple myeloma including the novel agents, thalidomide, bortezomib and lenalidomide.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Adams W (1872) Mollities ossium. Trans Pathol Soc Lond 23:186–187

    Google Scholar 

  • Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S, Elliott PJ (1999) Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res 59:2615–2622

    PubMed  CAS  Google Scholar 

  • Alexanian R, Haut A, Khan AU, Lane M, McKelvey EM, Migliore PJ, Stuckey WJ Jr, Wilson HE (1969) Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens. JAMA 208:1680–1685

    Article  PubMed  CAS  Google Scholar 

  • Alwall N (1947) Urethane and stilbamidine in multiple myeloma: report on two cases. Lancet 2:388–389

    Article  PubMed  CAS  Google Scholar 

  • Arinkin MI (1929) Die intravitale Untersuchungsmethodik des Knochenmarks. Folia Haematologie 38:233–240

    Google Scholar 

  • Barlogie B, Alexanian R, Dicke KA, Zagars G, Spitzer G, Jagannath S, Horwitz L (1987) High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma. Blood 70:869–872

    PubMed  CAS  Google Scholar 

  • Bayne-Jones S, Wilson DW (1922) Immunological reactions of Bence Jones proteins. II. Differences between Bence Jones proteins from various sources. Bull Johns Hopkins Hosp 33:119–125

    CAS  Google Scholar 

  • Bayrd ED, Heck FJ (1947) Multiple myeloma: a review of eighty-three proved cases. JAMA 133:147–157

    CAS  Google Scholar 

  • Bence Jones H (1842) On gravel, calculus and gout; chiefly an application of Professor Liebig’s physiology to the prevention and cure of these diseases. Taylor & Walton, London

    Google Scholar 

  • Bence Jones H (1845) On the state in which the uric acid exists in the urine. R. Kinder, London

    Google Scholar 

  • Bence Jones H (1847) Chemical pathology. Lancet 2:88–92

    Article  Google Scholar 

  • Bence Jones H (1848) On the new substance occurring in the urine of a patient with mollities ossium. Philos Trans R Soc Lond 138:55–62

    Article  Google Scholar 

  • Bence Jones H (1870) The life and letters of Faraday. J. B. Lippincott, Philadelphia

    Google Scholar 

  • Bence Jones H (1929) An autobiography (with elucidations at later dates by his son, A.B. Bence Jones). Crusha & Sons, London (privately printed)

    Google Scholar 

  • Bergsagel DE, Sprague CC, Austin C, Griffith KM (1962) Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV. L-Phenylalanine mustard (NSC-8806). Cancer Chemother Rep 21:87–99

    PubMed  CAS  Google Scholar 

  • Blokhin N, Larionov L, Perevodchikova N, Chebotareva L, Merkulova N (1958) Clinical experiences with sarcolysin in neoplastic diseases. Ann NY Acad Sci 68:1128–1132

    Article  PubMed  CAS  Google Scholar 

  • Cajal SR (1896) Estudios histologicos sobre los tumores epiteliales. Rev Trimest Microgr 1:83–111

    Google Scholar 

  • Capasso LL (2005) Antiquity of cancer. Int J Cancer 113:2–13

    Article  PubMed  CAS  Google Scholar 

  • Case DC Jr, Lee DJ III, Clarkson BD (1977) Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol. Am J Med 63:897–903

    Article  PubMed  Google Scholar 

  • Ciechanover A (1994) The ubiquitin-proteasome proteolytic pathway. Cell 79:13–21

    Article  PubMed  CAS  Google Scholar 

  • D’Amato RJ, Loughnan MS, Flynn E, Folkman J (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91:4082–4085

    Article  PubMed  Google Scholar 

  • Day WH (1870) On the hypophosphites of iron, quinine, and strychnia in cases of general debility and nervous exhaustion. Trans Clin Soc Lond 3:1–7

    Google Scholar 

  • Dimopoulos M, Spencer A, Attal M, Prince HM, Harousseau JL, Dmoszynska A, San Miguel J, Hellmann A, Facon T, Foa R, Corso A, Masliak Z, Olesnyckyj M, Yu Z, Patin J, Zeldis JB, Knight RD (2007) Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma. N Engl J Med 357:2123–2132

    Article  PubMed  CAS  Google Scholar 

  • Edelman GM, Gally JA (1962) The nature of Bence-Jones proteins. Chemical similarities to polypetide chains of myeloma globulins and normal gamma-globulins. J Exp Med 116:207–227

    Article  PubMed  CAS  Google Scholar 

  • Fefer A, Cheever MA, Greenberg PD (1986) Identical-twin (syngeneic) marrow transplantation for hematologic cancers. J Natl Cancer Inst 76:1269–1273

    PubMed  CAS  Google Scholar 

  • Felter HW, Lloyd JU (1898–1900) King’s American dispensatory. Ohio Valley Co, Cincinatti

    Google Scholar 

  • Fleischer R (1880) Ueber das Vorkommen des sogenannten Bence Jones’ schen Eiweisskorpers im normalen Knochenmark. Arch Pathol Anat Physiol Klin Med 80:842–849

    Google Scholar 

  • Gahrton G, Tura S, Flesch M, Gratwohl A, Gravett P, Lucarelli G, Michallet M, Reiffers J, Ringden O, van Lint MT et al (1987) Bone marrow transplantation in multiple myeloma: report from the European Cooperative Group for Bone Marrow Transplantation. Blood 69:1262–1264

    PubMed  CAS  Google Scholar 

  • Geschickter CF, Copeland MM (1928) Multiple myeloma. Arch Surg 16:807–863

    Google Scholar 

  • Gestsdottir H, Eyjolfsson GI (2005) Myeloma in an archaeological skeleton from Hofstadir in Myvatnssveit. Laeknabladid 91:505–509

    PubMed  Google Scholar 

  • Grabar P, Williams CA (1953) Method permitting the combined study of the electrophoretic and the immunochemical properties of protein mixtures; application to blood serum. Biochim Biophys Acta 10:193–194

    Article  PubMed  CAS  Google Scholar 

  • Grabstald H, Golbey R (1965) Clinical experiences with thalidomide in patients with cancer. Clin Pharmacol Ther 6:298–302

    PubMed  CAS  Google Scholar 

  • Hanna F (2005) Multiple myelomas in cats. J Feline Med Surg 7:275–287

    Article  PubMed  Google Scholar 

  • Harley JB, Ramanan SV, Kim I, Thiagarajan PV, Chen JH, Gomez R, Koppel D, Hyde F, Gustke S, Krall J (1972) The cyclic use of multiple alkylating agents in multiple myeloma. W V Med J 68:1–3

    PubMed  CAS  Google Scholar 

  • Harley JB, Pajak TF, McIntyre OR, Kochwa S, Cooper MR, Coleman M, Cuttner J (1979) Improved survival of increased-risk myeloma patients on combined triple-alkylating-agent therapy: a study of the CALGB. Blood 54:13–22

    PubMed  CAS  Google Scholar 

  • Heller JD (1846) Die mikroscopisch-chemisch-pathologische untersuchung. Braumuller & Seidel, Vienna

    Google Scholar 

  • Heremans JF (1959) Immunochemical studies on protein pathology. The immunoglobulin concept. Clin Chim Acta 4:639–646

    Article  PubMed  CAS  Google Scholar 

  • Herrick JB, Hektoen L (1894) Myeloma: report of a case. Med News, Philadelphia 65:239–242

    Google Scholar 

  • Hideshima T, Richardson P, Chauhan D, Palombella VJ, Elliott PJ, Adams J, Anderson KC (2001) The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res 61:3071–3076

    PubMed  CAS  Google Scholar 

  • Holland JR, Hosley H, Scharlau C, Carbone PP, Frei E III, Brindley CO, Hall TC, Shnider BI, Gold GL, Lasagna L, Owens AH Jr, Miller SP (1966) A controlled trial of urethane treatment in multiple myeloma. Blood 27:328–342

    PubMed  CAS  Google Scholar 

  • Hoogstraten B, Sheehe PR, Cuttner J, Cooper T, Kyle RA, Oberfield RA, Townsend SR, Harley JB, Hayes DM, Costa G, Holland JF (1967) Melphalan in multiple myeloma. Blood 30:74–83

    PubMed  CAS  Google Scholar 

  • Ishizaka K, Ishizaka T, Hornbrook MM (1966) Physicochemical properties of reaginic antibody. V. correlation of reaginic activity with gamma-E-globulin antibody. J Urol 97:840–853

    CAS  Google Scholar 

  • Kahler O (1889) Zur symptomatologie des multiplen myeloms: Beobachtung von Albumosurie. Prager Med Wochenschr (Prague) 14:45

    Google Scholar 

  • Korngold L, Lipari R (1956) Multiple myeloma proteins. III. The antigenic relationship of Bence Jones proteins to normal gammaglobulin and multiple myeloma serum proteins. Cancer 9:262–272

    Article  PubMed  CAS  Google Scholar 

  • Kühne (1883) Ueber Hemialbumose im Harn. Z Biol 19:209–227

    Google Scholar 

  • Kunkel HG, Tiselius A (1951) Electrophoresis of proteins on filter paper. J Gen Physiol 35:89–118

    Article  PubMed  CAS  Google Scholar 

  • Kyle RA (1978) Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. Am J Med 64:814–826

    Article  PubMed  CAS  Google Scholar 

  • Kyle RA (2000) Multiple myeloma: an odyssey of discovery. Br J Haematol 111:1035–1044

    Article  PubMed  CAS  Google Scholar 

  • Kyle RA (2001) Henry Bence Jones — physician, chemist, scientist and biographer: a man for all seasons. Br J Haematol 115:13–18

    Article  PubMed  CAS  Google Scholar 

  • Lee BJ, Sahakian G, Clarkson BD, Krakoff IH (1974) Proceedings: combination chemotherapy of multiple myeloma with alkeran, cytoxan, vincristine, prednisone, and BCNU. Cancer 33:533–538

    Article  PubMed  CAS  Google Scholar 

  • Lenz W (1962) Thalidomide and congenital abnormalities. Lancet 1:45

    Article  Google Scholar 

  • Lerner AB, Watson CJ (1947) Studies of cryoglobulins; unusual purpura associated with the presence of a high concentration of cryoglobulin (cold precipitable serum globulin). Am J Med Sci 214:410–415

    Article  PubMed  CAS  Google Scholar 

  • Longsworth AB, Shedlovsky T, MacInnes DA (1939) Electrophoretic patterns of normal and pathological human blood serum and plasma. J Exp Med 70:399–413

    Article  PubMed  CAS  Google Scholar 

  • Macintyre W (1850) Case of mollities and fragilitas ossium, accompanied with urine strongly charged with animal matter. Med Chir Trans 33:211–232

    PubMed  CAS  Google Scholar 

  • Marschalko T (1895) Ueber die sogenannten plasmazellen, ein Beitrage zur Kenntniss der Herkunft der entzundlichen infiltrationszellen. Arch Dermatol Syph 30:241

    Article  Google Scholar 

  • Mass RE (1962) A comparison of the effect of prednisone and a placebo in the treatment of multiple myeloma. Cancer Chemother Rep 16:257–259

    PubMed  CAS  Google Scholar 

  • McIntyre OR, Pajak TF, Kyle RA, Cornwell GG, Leone L (1985) Response rate and survival in myeloma patients receiving prednisone alone. Med Pediatr Oncol 13(5):239–243

    Google Scholar 

  • McElwain TJ, Powles RL (1983) High-dose intravenous melphalan for plasma-cell leukaemia and myeloma. Lancet 2:822–824

    Article  PubMed  CAS  Google Scholar 

  • Morse D, Dailey RC, Bunn J (1974) Prehistoric multiple myeloma. Bull New York Acad Med 50:447–458

    CAS  Google Scholar 

  • Myeloma Trialists’ Collaborative Group (1998) Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. J Clin Oncol 16:3832–3842

    Google Scholar 

  • Nerlich AG, Rohrbach H, Bachmeier B, Zink A (2006) Malignant tumors in two ancient populations: an approach to historical tumor epidemiology. Oncol Rep 16:197–202

    PubMed  Google Scholar 

  • Nothnagel H (1893) Hofrath Otto Kahler. Wien Klin Wochenschr (Wien) 6:79–80

    Google Scholar 

  • Obituary (1873). Henry Bence Jones, M.D., F.R.C.P., F.R.S. Med Times Gaz 1:505

    Google Scholar 

  • Olson KB, Hall TC, Horton J, Khung CL, Hosley HF (1965) Thalidomide (N-Phthaloylglutamimide) in the treatment of advanced cancer. Clin Pharmacol Ther 6:292–297

    PubMed  CAS  Google Scholar 

  • Orlowski RZ, Eswara JR, Lafond-Walker A, Grever MR, Orlowski M, Dang CV (1998) Tumor growth inhibition induced in a murine model of human Burkitt’s lymphoma by a proteasome inhibitor. Cancer Res 58:4342–4348

    PubMed  CAS  Google Scholar 

  • Orlowski RZ, Stinchcombe TE, Mitchell BS, Shea TC, Baldwin AS, Stahl S, Adams J, Esseltine DL, Elliott PJ, Pien CS, Guerciolini R, Anderson JK, Depcik-Smith ND, Bhagat R, Lehman MJ, Novick SC, O’Connor OA, Soignet SL (2002) Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies. J Clin Oncol 20:4420–4427

    Article  PubMed  CAS  Google Scholar 

  • Osserman EF, DiRe LB, DiRe J, Sherman WH, Hersman JA, Storb R (1982) Identical twin marrow transplantation in multiple myeloma. Acta Haematol 68:215–223

    Article  PubMed  CAS  Google Scholar 

  • Perlzweig WA, Delrue G, Geschicter C (1928) Hyperproteinemia associated with multiple myelomas: report of an unusual case. JAMA 90:755–757

    Google Scholar 

  • Peters GA, Horton BT (1941) Allergic purpura with special reference to hypersensitiveness to cold. Mayo Clin Proc 16:631–636

    Google Scholar 

  • Putnam FW (1993) Henry Bence Jones: the best chemical doctor in London. Perspect Biol Med 36:565–579

    PubMed  CAS  Google Scholar 

  • Rajkumar SV, Hayman SR, Lacy MQ, Dispenzieri A, Geyer SM, Kabat B, Zeldenrust SR, Kumar S, Greipp PR, Fonseca R, Lust JA, Russell SJ, Kyle RA, Witzig TE, Gertz MA (2005) Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma. Blood 106:4050–4053

    Article  PubMed  CAS  Google Scholar 

  • Richardson PG, Schlossman RL, Weller E, Hideshima T, Mitsiades C, Davies F, LeBlanc R, Catley LP, Doss D, Kelly K, McKenney M, Mechlowicz J, Freeman A, Deocampo R, Rich R, Ryoo JJ, Chauhan D, Balinski K, Zeldis J, Anderson KC (2002) Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma. Blood 100:3063–3067

    Article  PubMed  CAS  Google Scholar 

  • Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin D, Rajkumar SV, Srkalovic G, Alsina M, Alexanian R, Siegel D, Orlowski RZ, Kuter D, Limentani SA, Lee S, Hideshima T, Esseltine DL, Kauffman M, Adams J, Schenkein DP, Anderson KC (2003) A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 348:2609–2617 [see comment]

    Article  PubMed  CAS  Google Scholar 

  • Richardson PG, Sonneveld P, Schuster MW, Irwin D, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, San-Miguel JF, Blade J, Boccadoro M, Cavenagh J, Dalton WS, Boral AL, Esseltine DL, Porter JB, Schenkein D, Anderson KC (2005) Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med 352:2487–2498

    Article  PubMed  CAS  Google Scholar 

  • Richardson PG, Blood E, Mitsiades CS, Jagannath S, Zeldenrust SR, Alsina M, Schlossman RL, Rajkumar SV, Desikan KR, Hideshima T, Munshi NC, Kelly-Colson K, Doss D, McKenney ML, Gorelik S, Warren D, Freeman A, Rich R, Wu A, Olesnyckyj M, Wride K, Dalton WS, Zeldis J, Knight R, Weller E, Anderson KC (2006) A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma. Blood 108:3458–3464

    Article  PubMed  CAS  Google Scholar 

  • Rosenbloom J (1919) An appreciation of Henry Bence Jones, M.D., F.R.S. (1814-1873). Ann Med Hist 2:262–264

    Google Scholar 

  • Rosenfeld L (1987) Henry Bence Jones (1813–1873): the best “chemical doctor” in London. Clin Chem 33:1687–1692

    PubMed  CAS  Google Scholar 

  • Rosenthal N, Vogel P (1938) Value of the sternal puncture in the diagnosis of multiple myeloma. Mt Sinai J Med 4:1001–1019

    Google Scholar 

  • Rothschild BM, Hershkovitz I, Dutour O (1998) Clues potentially distinguishing lytic lesions of multiple myeloma from those of metastatic carcinoma. Am J Phys Anthropol 105:241–250

    Article  PubMed  CAS  Google Scholar 

  • Rowe DS, Fahey JL (1965) A new class of human immunoglobulins. I. A unique myeloma protein. J Exp Med 121:171–184

    Article  PubMed  CAS  Google Scholar 

  • Salmon SE, Shadduck RK, Schilling A (1967) Intermittent high-dose prednisone (NSC-10023) therapy for multiple myeloma. Cancer Chemother Rep 51:179–187

    PubMed  CAS  Google Scholar 

  • Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeddis J, Barlogie B (1999) Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 341:1565–1571 [see comment] [erratum appears in N Engl J Med 3 Feb 2000; 342(5):364]

    Article  PubMed  CAS  Google Scholar 

  • Solly S (1844) Remarks on the pathology of mollities ossium with cases. Med Chir Trans 27:435–461

    PubMed  CAS  Google Scholar 

  • Steensma DP, Kyle RA (2007) A history of the kidney in plasma cell disorders. Contrib Nephrol 153:5–24

    Article  PubMed  CAS  Google Scholar 

  • Steinbock T (1976) Paleopathological diagnosis and interpretation. CC Thomas, Springfield

    Google Scholar 

  • Stephens JL (1994) Arrowroot — Maranta arundinacea L. In: Fact Sheet HS-542. A series of the Horticultural Sciences Department, Florida Cooperative Extension Service, Institute of Food and Agricultural Services, University of Florida, Gainsville

    Google Scholar 

  • Thomas ED, Lochte HL Jr, Lu WC, Ferrebee JW (1957) Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 257:491–496

    Article  PubMed  CAS  Google Scholar 

  • Tiselius A (1937a) Electrophoresis of serum globulin. II. Electrophoretic analysis of normal and immune sera. Biochem J 31:1464–1477

    PubMed  CAS  Google Scholar 

  • Tiselius A (1937b) A new apparatus for electrophoretic analysis of colloidal mixtures. T Faraday Soc 33:524

    Article  CAS  Google Scholar 

  • Tiselius A, Kabat EA (1939) Electrophoretic study of immune sera and purified antibody preparation. J Exp Med 69:119–131

    Article  PubMed  CAS  Google Scholar 

  • von Behring EA, Kisato S (1890) Ueber das Zustandekommen der Diphtherie-Immunitat und der Tetanus-Immunitat bei Theieren. Dtsch Med Wochenschr 49:1113–1114

    Google Scholar 

  • Waldenstrom J (1960–1961) Studies on conditions associated with disturbed gamma globulin formation (gammopathies). Harvey Lect 56:211–231

    Google Scholar 

  • Waldeyer W (1875) Ueber bindegewebszellen. Arch Microbiol Anat 11:176–194

    Article  Google Scholar 

  • Weber H (1867) Mollities ossium, doubtful whether carcinomatous or syphilitic. Trans Pathol Soc Lond 23:186–187

    Google Scholar 

  • Weber FP (1898) General lymphadenomatosis of bones, one form of ‘multiple myeloma’. J Pathol 5:59–64

    Article  Google Scholar 

  • Weber FP, Hutchinson R, Macleod JJR (1903) Multiple myeloma (myelomatosis), with Bence-Jones protein in the urine (myelopathic albumosuria of Bradshaw, Kahler’s disease). Am J Med Sci 126:644–665

    Article  Google Scholar 

  • Weber DM, Chen C, Niesvizky R, Wang M, Belch A, Stadtmauer EA, Siegel D, Borrello I, Rajkumar SV, Chanan-Khan AA, Lonial S, Yu Z, Patin J, Olesnyckyj M, Zeldis JB, Knight RD (2007) Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America. N Engl J Med 357:2133–2142

    Article  PubMed  CAS  Google Scholar 

  • Wells C (1964) Two mediaeval cases of malignant disease. BMJ 1:1611–1612

    PubMed  CAS  Google Scholar 

  • Wintrobe MM, Buell MV (1933) Hyperproteinemia associated with multiple myeloma, with report of a case in which an extraordinary hyperproteinemia was associated with thrombosis of the retinal veins and symptoms suggesting Raynaud’s disease. Bull Johns Hopkins Hosp 52:156–165

    Google Scholar 

  • Wright JH (1900) A case of multiple myeloma. Trans Assoc Am Physician 15:137–147

    Google Scholar 

  • Zink A, Rohrbach H, Szeimies U, Hagedorn HG, Haas CJ, Weyss C, Bachmeier B, Nerlich AG (1999) Malignant tumors in an ancient Egyptian population. Anticancer Res 19:4273–4277

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Hematology, Mayo Clinic, 200 First Street SW, Stabile 6-28, Rochester, MN, USA

    Robert A. Kyle

Authors
  1. Robert A. Kyle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David P. Steensma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert A. Kyle .

Editor information

Editors and Affiliations

  1. Medizinische Klinik und Poliklinik, Abt. Hämatologie, Onkologie und, Universitätsklinikum Heidelberg, Hospitalstr. 3, Heidelberg, 69115, Germany

    Thomas Moehler

  2. Medizinische Klinik und Poliklinik, Abt. Innere Medizin V, Universitätsklinikum Heidelberg, Hospitalstr. 3, Heidelberg, 69115, Germany

    Hartmut Goldschmidt

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kyle, R.A., Steensma, D.P. (2011). History of Multiple Myeloma. In: Moehler, T., Goldschmidt, H. (eds) Multiple Myeloma. Recent Results in Cancer Research, vol 183. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-85772-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-85772-3_1

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-85771-6

  • Online ISBN: 978-3-540-85772-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation